Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.

about

Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Elevated tumour necrosis factor-alpha was associated with intima thickening in obese children.

P2860

Q36953626-188F56B4-4A57-4A11-8F1E-24904D08F8F3 Q51226406-03FFD316-120C-4FC6-9E26-BC02929BADB3

P2860

Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.

Item

http://www.wikidata.org/entity/Q41190292

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hepatic insulin resistance in ...... metabolic syndrome components.

@en

type

Item

label

Hepatic insulin resistance in ...... metabolic syndrome components.

@en

prefLabel

Hepatic insulin resistance in ...... metabolic syndrome components.

@en

P1476

Hepatic insulin resistance in ...... metabolic syndrome components.

@en

P2093

Agata Maria Rabuazzo

http://www.w3.org/2001/XMLSchema#string

Corradina Alagona

http://www.w3.org/2001/XMLSchema#string

Francesco Purrello

http://www.w3.org/2001/XMLSchema#string

Graziella Privitera

http://www.w3.org/2001/XMLSchema#string

Luisa Spadaro

http://www.w3.org/2001/XMLSchema#string

Salvatore Calanna

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.

Fatty liver: a novel component of the metabolic syndrome.

Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

The role of non-alcoholic fatty liver disease in cardiovascular disease.

Nonalcoholic fatty liver disease and the coronary artery disease.

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

P2888

s00592-015-0816-y

P304

449-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00592-015-0816-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Piro

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26496770

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.

about

P2860

P2860

Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921